Cargando…

Association study of matrix metalloproteinase 3 5A/6A polymorphism with in-stent restenosis after percutaneous coronary interventions in a Han Chinese population

OBJECTIVE: We aimed to investigate the association between the 5A/6A promoter polymorphism in the matrix metalloproteinase 3 (MMP3) gene and in-stent restenosis (ISR) in a regional Chinese population. METHODS: A total of 818 patients who underwent primary implantation of drug-eluting stents were enr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Du, Ji-Bing, Zhang, Wei, Li, Na, Jiang, Hua, Liu, Yin, Gao, Jing, Chen, Shu-Tao, Cong, Hong-Liang, Wei, Yi-Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Special Issue: Prevention and Treatment of Cardiovascular Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140217/ https://www.ncbi.nlm.nih.gov/pubmed/30732526 http://dx.doi.org/10.1177/0300060519827145

Ejemplares similares

Three-year follow-up of composite stent grafts used in the repair of Crawford Type III thoracoabdominal aortic aneurysms; A case report
por: Tong, Yuan-hao, et al.
Publicado: (2019)

D-dimer as a thrombus biomarker for predicting 2-year mortality after percutaneous coronary intervention
por: Zhao, Xueyan, et al.
Publicado: (2020)

Chronic stress: a crucial promoter of cell apoptosis in atherosclerosis
por: Meng, Ling-bing, et al.
Publicado: (2019)

Effects of a Matrix Metalloproteinase Inhibitor-Eluting Stent on In-Stent Restenosis
por: Song, Jian-bo, et al.
Publicado: (2020)

Cardiovascular computed tomography versus transoesophageal echocardiography after cryptogenic ischaemic stroke – a pilot study of 12 patients
por: Resen, Mette Sørensen, et al.
Publicado: (2018)

Using A Body Shape Index (ABSI) and Body Roundness Index (BRI) to predict risk of metabolic syndrome in Peruvian adults
por: Stefanescu, Andrei, et al.
Publicado: (2019)

Serum adenosine deaminase activity and coronary artery disease: a retrospective case-control study based on 9929 participants
por: Xuan, Chao, et al.
Publicado: (2019)

Electrocardiographic manifestations in severe hypokalemia
por: Wang, Xiqiang, et al.
Publicado: (2018)

Knowledge of an inflammatory biomarker of cardiovascular risk leads to biomarker-based decreased risk in pre-diabetic and diabetic patients
por: Alcivar-Franco, Diego, et al.
Publicado: (2018)

Astragaloside IV promotes the eNOS/NO/cGMP pathway and improves left ventricular diastolic function in rats with metabolic syndrome
por: Lin, Xin, et al.
Publicado: (2019)

Effect of statin treatment on circulating malondialdehyde concentrations: a systematic review and meta-analysis
por: Zinellu, Angelo, et al.
Publicado: (2019)

Targeted metabolomic analysis of serum phospholipid and acylcarnitine in the adult Fontan patient with a dominant left ventricle
por: Michel, Miriam, et al.
Publicado: (2020)

Net benefit of statins for primary prevention of cardiovascular disease in people 75 years or older: a benefit–harm balance modeling study
por: Yebyo, Henock G., et al.
Publicado: (2019)

Noninvasive imaging assessment of rehabilitation therapy in heart failure with preserved and reduced left ventricular ejection fraction (IMAGING-REHAB-HF): design and rationale
por: Cardoso, Fernando Bianchini, et al.
Publicado: (2019)

The history of proprotein convertase subtilisin kexin-9 inhibitors and their role in the treatment of cardiovascular disease
por: Kim, Eun Ji, et al.
Publicado: (2020)

Role of Sfrps in cardiovascular disease
por: Huang, Anqing, et al.
Publicado: (2020)

Predictors of restenosis following percutaneous coronary stent implantation: The role of trimetazidine therapy
por: Csató, Gábor, et al.
Publicado: (2022)

Management of multivessel coronary artery disease in patients with non-ST-elevation myocardial infarction: a complex path to precision medicine
por: Baumann, Angus A. W., et al.
Publicado: (2020)

Pathophysiology of chronic peripheral ischemia: new perspectives
por: Signorelli, Salvatore Santo, et al.
Publicado: (2020)

Current approach to the diagnosis of atherosclerotic coronary artery disease: more questions than answers
por: Nelson, Adam J., et al.
Publicado: (2019)

The prognostic values of matrix metalloproteinases in ovarian cancer
por: Zeng, Linchai, et al.
Publicado: (2019)

Matrix metalloproteinase 9 level as an indicator for restenosis following cervical and intracranial angioplasty and stenting
por: Liu, Jun-peng, et al.
Publicado: (2015)

Serum glycated albumin is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents: An observational study
por: Lin, Xiao Long, et al.
Publicado: (2022)

Serial optical coherence tomography and angioscopic assessments of 10-year in-stent restenosis of Cypher sirolimus-eluting stent treated with drug-coated balloon angioplasty
por: Suzuki, Satoshi, et al.
Publicado: (2019)

Impact of anemia on in-stent restenosis after percutaneous coronary intervention
por: Hu, Huilin, et al.
Publicado: (2021)

Heavy Coronary Calcium Mimicking In-Stent Restenosis
por: Park, Jeong-Hwan, et al.
Publicado: (2011)

Intravascular imaging in coronary stent restenosis: Prevention, characterization, and management
por: Abouelnour, Amr, et al.
Publicado: (2022)

Time dependent integration of matrix metalloproteinases and their targeted substrates directs axonal sprouting and synaptogenesis following central nervous system injury
por: Phillips, Linda L., et al.
Publicado: (2014)

In stent restenosis after percutaneous coronary intervention
por: Eyüboğlu, Mehmet
Publicado: (2016)

Relationship between ALDH2 genotype and in-stent restenosis in Chinese Han patients after percutaneous coronary intervention
por: Lv, Lizhi, et al.
Publicado: (2019)

Percutaneous Coronary Intervention vs. Coronary Artery Bypass Grafting for Treating In-Stent Restenosis in Unprotected-Left Main: LM-DRAGON-Registry
por: Wańha, Wojciech, et al.
Publicado: (2022)

Prevalence, predictors, and management for balloon uncrossable or undilatable lesions in patients undergoing percutaneous coronary intervention with in-stent restenosis chronic total occlusion
por: Wang, Yong, et al.
Publicado: (2023)

Unusually aggressive immature neo-intimal hyperplasia causing in-stent restenosis
por: Keir, McCutcheon, et al.
Publicado: (2017)

The number of stents was an independent risk of stent restenosis in patients undergoing percutaneous coronary intervention
por: Tang, Long, et al.
Publicado: (2019)

Plasma Proteome Profiling of Patients With In-stent Restenosis by Tandem Mass Tag-Based Quantitative Proteomics Approach
por: Hou, Jingyuan, et al.
Publicado: (2022)

Cardiac CT in Detecting a Dislodged Stent in Right Coronary Artery after Primary Percutaneous Coronary Intervention
por: Ashraf, Tariq, et al.
Publicado: (2019)

The management of carotid restenosis: a comprehensive review
por: Stilo, Francesco, et al.
Publicado: (2020)

Risk investigation of in-stent restenosis after initial implantation of intracoronary drug-eluting stent in patients with coronary heart disease
por: Xi, Hongfei, et al.
Publicado: (2023)

Proinflammatory Matrix Metalloproteinase-1 Associates With Mitral Valve Leaflet Disruption Following Percutaneous Mitral Valvuloplasty
por: Passos, Livia S. A., et al.
Publicado: (2022)

Coronary stent restenosis and the association with allergy to metal content of 316L stainless steel
por: D, Slodownik, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7nh517l6cb45ukuj6qu40lpcrs